Literature DB >> 6276200

[3H]rauwolscine (alpha-yohimbine): a specific antagonist radioligand for brain alpha 2-adrenergic receptors.

B D Perry, D C U'Prichard.   

Abstract

[3H]Rauwolscine, a specific and potent alpha 2-antagonist radioligand, was used to characterize alpha 2-receptor binding in bovine cerebral cortex. [3H]Rauwolscine binding was reversible, stereospecific, and saturable. Association, dissociation, and saturation studies revealed one site interactions (k -1/k+1 = 1.2 nM, KD = 2.5 nM, Bmax = 160 fmol/mg protein) and competition studies indicated that [3H]rauwolscine labeled the alpha 2-receptor. Agonists inhibited [3H]rauwolscine binding in a shallow, GTP-sensitive manner. These results suggest that [3H]rauwolscine specifically labels both the high and low affinity states of the alpha 2-receptor in brain membranes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6276200     DOI: 10.1016/0014-2999(81)90123-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  22 in total

1.  Alpha-adrenergic inhibition increases collateral circuit conductance in rats following acute occlusion of the femoral artery.

Authors:  Jessica C Taylor; Zeyi Li; H T Yang; M Harold Laughlin; Ronald L Terjung
Journal:  J Physiol       Date:  2008-01-24       Impact factor: 5.182

2.  [3H]L-654,284 as a probe of the central alpha 2 adrenoceptor.

Authors:  W C Randall; J R Huff; J P Vacca; J P Guare; R Chen; A Rosegay; J J Baldwin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

3.  Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor.

Authors:  D R Thomas; D R Nelson; A M Johnson
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  A study of the sensitivity of rat brain alpha 2-adrenoceptors during chronic antidepressant treatments.

Authors:  M F Sugrue
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-08       Impact factor: 3.000

5.  Lesioning of serotoninergic and noradrenergic nerve fibres of the rat brain does not decrease binding of 3H-clonidine and 3H-rauwolscine to cortical membranes.

Authors:  G Gross; M Göthert; U Glapa; G Engel; H J Schümann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

6.  Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.

Authors:  R S Chang; V J Lotti
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

7.  Receptor inhibition by immunoglobulins: specific inhibition by autistic children, their relatives, and control subjects.

Authors:  E H Cook; B D Perry; G Dawson; M S Wainwright; B L Leventhal
Journal:  J Autism Dev Disord       Date:  1993-03

8.  Interaction of the component enantiomers of the putative dopamine autoreceptor agonist, TL-99 (6,7-dihydroxy-2-dimethylamino tetralin) with dopaminergic systems in mammalian brain and teleost retina.

Authors:  M Williams; G E Martin; D E McClure; J J Baldwin; K J Watling
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

9.  Evidence for pharmacological similarity between alpha 2-adrenoceptors in the vas deferens and central nervous system of the rat.

Authors:  J C Doxey; B Gadie; A C Lane; I F Tulloch
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

10.  Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations.

Authors:  J Schloos; A Wellstein; D Palm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.